​

Embecta (EMBC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

EMBC Stock Forecast

Embecta (EMBC) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $25.00, with a high of $25.00 and a low of $25.00. This represents a 139.23% increase from the last price of $10.45.

$10 $13 $16 $19 $22 $25 High: $25 Avg: $25 Low: $25 Last Closed Price: $10.45

EMBC Stock Rating

Embecta stock's rating consensus is Sell, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 1 Buy (25.00%), 1 Hold (25.00%), 2 Sell (50.00%), and 0 Strong Sell (0.00%).

Sell
Total 4 0 2 1 1 Strong Sell Sell Hold Buy Strong Buy

EMBC Price Target Upside V Benchmarks

TypeNameUpside
StockEmbecta139.23%
SectorHealthcare Stocks 19.91%
IndustrySpecialty & Generic Drug Manufacturers Stocks27.79%

Price Target Trends

1M3M12M
# Anlaysts-13
Avg Price Target-$25.00$23.67
Last Closing Price$10.45$10.45$10.45
Upside/Downside-139.23%126.51%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 25-12-14
Jun, 25-13-15
May, 25-13-15
Apr, 25-12-14
Mar, 25-12-14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 23, 2025Marie ThibaultBTIG$25.00$10.72133.21%139.23%
Dec 02, 2024Kallum TitchmarshMorgan Stanley$20.00$20.68-3.29%91.39%
Nov 27, 2024Marie ThibaultBTIG$26.00$19.8031.31%148.80%
Jul 15, 2024Kallum TitchmarshMorgan Stanley$12.00$13.17-8.88%14.83%
Aug 16, 2022Morgan Stanley$36.00$33.427.72%244.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 23, 2025BTIGBuyBuyhold
Dec 02, 2024Morgan StanleyUnderweightOverweightupgrade
Nov 27, 2024BTIGBuyupgrade
Jul 15, 2024Morgan StanleyUnderweightUnderweighthold
May 15, 2023Morgan StanleyUnderweightUnderweighthold
Jun 21, 2022Bank of America SecuritiesUnderperforminitialise

Financial Forecast

EPS Forecast

Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28
Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28
Reported$3.92$1.23$1.36----
Avg Forecast$4.54$2.80$2.39$2.27$2.32$1.61$1.50
High Forecast$4.59$2.84$2.56$2.44$3.13$1.63$1.52
Low Forecast$4.50$2.75$2.29$2.09$1.80$1.60$1.49
Surprise %-13.66%-56.07%-43.10%----

Revenue Forecast

$1B $1B $1B $1B $1B $1B Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28
Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28
Reported$1.13B$1.12B$1.12B----
Avg Forecast$1.12B$1.11B$1.11B$1.12B$1.13B$1.13B$1.15B
High Forecast$1.13B$1.12B$1.13B$1.13B$1.13B$1.15B$1.16B
Low Forecast$1.11B$1.11B$1.11B$1.11B$1.13B$1.11B$1.14B
Surprise %1.13%0.81%0.77%----

Net Income Forecast

$50M $100M $150M $200M $250M $300M Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28
Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28
Reported$223.60M$70.40M$78.30M----
Avg Forecast$262.22M$161.44M$140.08M$130.71M$119.00M$92.99M$86.64M
High Forecast$265.37M$164.01M$148.02M$140.76M$181.00M$94.15M$87.72M
Low Forecast$260.15M$158.87M$132.14M$120.65M$103.72M$92.30M$85.99M
Surprise %-14.73%-56.39%-44.10%----

EMBC Forecast FAQ

Is Embecta stock a buy?

Embecta stock has a consensus rating of Sell, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 1 Buy, 1 Hold, 2 Sell, and 0 Strong Sell, reflecting a consensus that Embecta is a less favorable investment for most analysts.

What is Embecta's price target?

Embecta's price target, set by 4 Wall Street analysts, averages $25 over the next 12 months. The price target range spans from $25 at the low end to $25 at the high end, suggesting a potential 139.23% change from the previous closing price of $10.45.

How does Embecta stock forecast compare to its benchmarks?

Embecta's stock forecast shows a 139.23% upside, outperforming the average forecast for the healthcare stocks sector (19.91%) and outperforming the specialty & generic drug manufacturers stocks industry (27.79%).

What is the breakdown of analyst ratings for Embecta over the past three months?

  • July 2025: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 25.00% Strong Sell.
  • June 2025: 0% Strong Buy, 20.00% Buy, 60.00% Hold, 0% Sell, 20.00% Strong Sell.
  • May 2025: 0% Strong Buy, 20.00% Buy, 60.00% Hold, 0% Sell, 20.00% Strong Sell.

What is Embecta’s EPS forecast?

Embecta's average annual EPS forecast for its fiscal year ending in September 2025 is $2.27, marking a 66.91% increase from the reported $1.36 in 2024. Estimates for the following years are $2.32 in 2026, $1.61 in 2027, and $1.5 in 2028.

What is Embecta’s revenue forecast?

Embecta's average annual revenue forecast for its fiscal year ending in September 2025 is $1.12B, reflecting a -0.26% decrease from the reported $1.12B in 2024. The forecast for 2026 is $1.13B, followed by $1.13B for 2027, and $1.15B for 2028.

What is Embecta’s net income forecast?

Embecta's net income forecast for the fiscal year ending in September 2025 stands at $130.71M, representing an 66.93% increase from the reported $78.3M in 2024. Projections indicate $119M in 2026, $92.99M in 2027, and $86.64M in 2028.